Rodman David Malcom's Form 4 filing
Mineralys Therapeutics, Inc. (MLYS) · filed Jan 6, 2026
- Accession no.
- 0001672659-26-000002
- Filed
- Jan 6, 2026
- Trade date
- Jan 2-5, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 13 non-derivative transactions and 10 derivative transactions. Open-market sales total $9.26M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rodman David MalcomCIK 0001672659 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +10,053 | $1.08 | +$10,857.24 | 81,888 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +3,629 | $15.44 | +$56,031.76 | 85,517 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +9,347 | $10.20 | +$95,339.4 | 94,864 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +20,168 | $16.00 | +$322,688 | 115,032 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +24,193 | $14.25 | +$344,750.25 | 139,225 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −70,037 | $35.87 | −$2,512,227.19 | 69,188 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +28,038 | $1.08 | +$30,281.04 | 97,226 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +10,121 | $15.44 | +$156,268.24 | 107,347 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +26,069 | $10.20 | +$265,903.8 | 133,416 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +53,630 | $16.00 | +$858,080 | 187,046 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +67,473 | $14.25 | +$961,490.25 | 254,519 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −139,245 | $34.83 | −$4,849,903.35 | 115,274 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −53,470 | $35.53 | −$1,899,789.1 | 61,804 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −10,053 | $0.00 | $0 | 72,478 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −3,629 | $0.00 | $0 | 16,371 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −9,347 | $0.00 | $0 | 160,653 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −20,168 | $0.00 | $0 | 84,018 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −24,193 | $0.00 | $0 | 175,807 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −28,038 | $0.00 | $0 | 44,440 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −10,121 | $0.00 | $0 | 6,250 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −26,069 | $0.00 | $0 | 134,584 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −53,630 | $0.00 | $0 | 30,388 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −67,473 | $0.00 | $0 | 108,334 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.